Home » Topics » Regulatory

Regulatory
RSS

FDA approves abbreviated treatment regimen for Vantin

June 21, 1996

Positive phase III results for new Solarase formulation

June 21, 1996

Vivus and Astra sign Muse licensing agreement

June 14, 1996

Schering-Plough seeks Nasonex approval

June 14, 1996

Activase cleared by FDA for ischemic stroke

June 14, 1996

Colchicine/hydroxychloroquine therapy of AD

June 14, 1996

Lithium/nimodipine combination as bipolar I manic disorder treatment

June 14, 1996

Xalatan approved for U.S. market

June 14, 1996

Actimmune metastatic renal cell carcinoma development terminated

June 14, 1996

Augmentin's new dosing/formulation cleared by FDA

June 14, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...